ArticleBlood advances2025

EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy.

Dua'a Zandaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.